Nihar Info Global Ltd received shareholder approval for all 10 resolutions at its 32nd Annual General Meeting, including a strategic capital raise and subsidiary divestment. The company is set to issue over 1.1 million equity shares to non-promoters and 2 million convertible warrants to promoters. Additionally, shareholders cleared the divestment of its stakes in Life 108 Healthcare and Beastbells Media. Investors should monitor future updates on the actual allotment process and the completion of the divestment strategy.
Nihar Info Global Shareholders Approve Strategic Capital Raise and Divestment Plan
Nihar Info Global Ltd has secured shareholder approval for the issuance of 1,170,000 equity shares and 2,000,000 convertible warrants.
Reader Takeaway: Management gains mandate for capital infusion and portfolio cleanup, though dilution and execution timeline remain key points.
What just happened
The company held its 32nd Annual General Meeting on September 30, 2026, where shareholders approved all 10 proposed resolutions. The core decisions involve a major capital restructuring through both preferential share issuance and the divestment of specific subsidiary interests.
Why this matters
The approval paves the way for fresh capital injection into the company. By issuing 1,170,000 equity shares to non-promoters and 2,000,000 convertible warrants to the promoter group, the company is positioning itself for potential expansion or working capital requirements. Simultaneously, exiting the Life 108 Healthcare and Beastbells Media subsidiaries indicates a shift in the company’s business focus.
Governance Update
The AGM solidified the leadership structure by re-appointing Mrs. Vijaya Lakshmi Boda as Director. Furthermore, Mr. Annapantula Seetarama Murthy has been regularized as an Independent Director, strengthening the company’s board oversight. M/s Surya Gupta & Associates has been confirmed as the Secretarial Auditor for the next five years.
What to track next
Investors should keep a close watch on future BSE filings regarding the actual date of allotment for the shares and warrants. Additionally, updates regarding the financial terms and closure of the divestment of the two subsidiaries will be critical in assessing the company’s revised asset profile.
